Corrigendum to “Terlipressin and albumin for type-1 hepatorenal syndrome associated with sepsis” [J Hepatol 2014; 60: 955–961]

Terlipressin and albumin for type-1 hepatorenal syndrome associated with sepsisJournal of HepatologyVol. 60Issue 5PreviewTerlipressin and albumin is the standard of care for classical type-1 hepatorenal syndrome (HRS) not associated with active infections. However, there is no information on efficacy and safety of this treatment in patients with type-1 HRS associated with sepsis. Study aim was to investigate the effects of early treatment with terlipressin and albumin on circulatory and kidney function in patients with type-1 HRS and sepsis and assess factors predictive of response to therapy. Full-Text PDF In this manuscript Fig. 2 contained a mistake. The correct Fig. 2 is now presented below. In this manuscript Fig. 2 contained a mistake. The correct Fig. 2 is now presented below.